BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21311098)

  • 1. NSP 5a3a: a potential novel cancer target in head and neck carcinoma.
    D'agostino L; Giordano A
    Oncotarget; 2010 Oct; 1(6):423-435. PubMed ID: 21311098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSP 5a3a's link to nuclear-cyto proteins B23 and hnRNP-L between normal and aberrant breast cell lines.
    D'Agostino L; Caracciolo V; Giordano A
    Cell Cycle; 2010 Mar; 9(6):1131-42. PubMed ID: 20237420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel dual signaling axis for NSP 5a3a induced apoptosis in head and neck carcinoma.
    D'Agostino L; Giordano A
    Oncotarget; 2011 Dec; 2(12):1055-74. PubMed ID: 22170762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible functional role of NSPs in cancer.
    D'Agostino L; Giordano A
    Cell Cycle; 2008 Jun; 7(12):1810-27. PubMed ID: 18763323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells.
    Liu J; Uematsu H; Tsuchida N; Ikeda MA
    Mol Cancer; 2011 Jul; 10():95. PubMed ID: 21801448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E1A-mediated suppression of EGFR expression and induction of apoptosis in head and neck squamous carcinoma cell lines.
    Flinterman M; Gäken J; Farzaneh F; Tavassoli M
    Oncogene; 2003 Apr; 22(13):1965-77. PubMed ID: 12673202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of exogenous p53 overexpression on HPV-immortalized and carcinogen transformed oral keratinocytes.
    Yoo GH; Washington J; Oliver J; Piechocki M; Kim H; Foster-Nora J; Shibuya TY; Wilson DR; Ensley JF
    Cancer; 2002 Jan; 94(1):159-66. PubMed ID: 11815972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could NSP5a3a be a target for head and neck cancer?
    White MK; Khalili K
    Oncotarget; 2010 Oct; 1(6):386. PubMed ID: 21311094
    [No Abstract]   [Full Text] [Related]  

  • 10. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer.
    Lu H; Yang X; Duggal P; Allen CT; Yan B; Cohen J; Nottingham L; Romano RA; Sinha S; King KE; Weinberg WC; Chen Z; Van Waes C
    Cancer Res; 2011 Nov; 71(21):6867-77. PubMed ID: 21933882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine-induced anticancer activities in FaDu head and neck squamous cell carcinoma cells.
    Seo YS; Yim MJ; Kim BH; Kang KR; Lee SY; Oh JS; You JS; Kim SG; Yu SJ; Lee GJ; Kim DK; Kim CS; Kim JS; Kim JS
    Oncol Rep; 2015 Dec; 34(6):3025-34. PubMed ID: 26503508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.
    Nohata N; Hanazawa T; Kinoshita T; Inamine A; Kikkawa N; Itesako T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Br J Cancer; 2013 Apr; 108(8):1648-58. PubMed ID: 23558898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines.
    Liu X; Jiang L; Wang A; Yu J; Shi F; Zhou X
    Cancer Lett; 2009 Dec; 286(2):217-22. PubMed ID: 19540661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck.
    Yeudall WA; Jakus J; Ensley JF; Robbins KC
    Mol Carcinog; 1997 Feb; 18(2):89-96. PubMed ID: 9049184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival.
    Adams AK; Bolanos LC; Dexheimer PJ; Karns RA; Aronow BJ; Komurov K; Jegga AG; Casper KA; Patil YJ; Wilson KM; Starczynowski DT; Wells SI
    Oncotarget; 2015 Dec; 6(41):43395-407. PubMed ID: 26527316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z
    Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.